2715P Phase II trial of tildrakizumab in treatment-refractory bone and soft tissue sarcomas

Authors:
  • MKM. Kansara
    M. Kansara
  • FLF.P. Lin
    F.P. Lin
  • STS. Thavaneswaran
    S. Thavaneswaran
  • MHM.L. Huang
    M.L. Huang
  • MTM. Tran
    M. Tran
  • TCT. Corpuz
    T. Corpuz
  • JLJ. Lu
    J. Lu
  • DED. Espinoza
    D. Espinoza
  • SCS. Chinchen
    S. Chinchen
  • MBM. Ballinger
    M. Ballinger
  • PGP. Grimison
    P. Grimison
  • VAV. Andelkovic
    V. Andelkovic

Abstract
No abstract available
Funding Information
  • Bayer
  • Roche